Search research articles
Contact Us
Filters
Showing results (91-100 of 261) with videos related to
Page
of 27
Sort By:
European Journal of Cancer
|
November 1, 1973
Lymphocyte toxicity test in clinical melanoma
U Veronesi, N Cascinelli, G Fossati, et al.
Anticancer Research
|
November 1, 1996
Axillary dissection can be avoided in selected breast cancer patients: analysis of 401 cases
M Greco, R Agresti, R Raselli, et al.
Lancet (London, England)
|
January 29, 1999
Drop-outs in tamoxifen prevention trials
U Veronesi, P Maisonneuve, A Costa, et al.
The New England Journal of Medicine
|
August 13, 1992
Breast cancer (3)
J R Harris, M E Lippman, U Veronesi, et al.
International Advances in Surgical Oncology
|
January 1, 1978
New trends in the treatment of malignant melanoma
U Veronesi, E Bajetta, N Cascinelli, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
August 17, 2001
[Intraoperative radiotherapy (IORT) in treatment of breast carcinoma--a new therapeutic alternative within the scope of breast-saving therapy? Current status and future prospects. Report of experiences from the European Institute of Oncology (EIO), Mailand]
W Gatzemeier, R Orecchia, G Gatti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1983
Adjuvant CMF in breast cancer: comparative 5-year results of 12 versus 6 cycles
G Tancini, G Bonadonna, P Valagussa, et al.
Cancer
|
February 1, 1974
Proceedings: The value of staging laparotomy in non-Hodgkin's lymphomas (with emphasis on the histiocytic type)
U Veronesi, R Musumeci, F Pizzetti, et al.
International Advances in Surgical Oncology
|
January 1, 1983
The quadrantectomy, axillary dissection and radiotherapy (QU.A.RT) technique in early breast cancer
U Veronesi, M Del Vecchio, A Luini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 1, 1991
Chronic oral administration of fenretinide, as a chemopreventive agent to breast cancer patients, does not affect plasma alpha-tocopherol concentration
F Formelli, M Clerici, G De Palo, et al.
Page
of 27
Search research articles
Search
Showing results (91-100 of 261) with videos related to
Sort By:
Page
of 27
European Journal of Cancer
|
November 1, 1973
Lymphocyte toxicity test in clinical melanoma
U Veronesi, N Cascinelli, G Fossati, et al.
Anticancer Research
|
November 1, 1996
Axillary dissection can be avoided in selected breast cancer patients: analysis of 401 cases
M Greco, R Agresti, R Raselli, et al.
Lancet (London, England)
|
January 29, 1999
Drop-outs in tamoxifen prevention trials
U Veronesi, P Maisonneuve, A Costa, et al.
The New England Journal of Medicine
|
August 13, 1992
Breast cancer (3)
J R Harris, M E Lippman, U Veronesi, et al.
International Advances in Surgical Oncology
|
January 1, 1978
New trends in the treatment of malignant melanoma
U Veronesi, E Bajetta, N Cascinelli, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
August 17, 2001
[Intraoperative radiotherapy (IORT) in treatment of breast carcinoma--a new therapeutic alternative within the scope of breast-saving therapy? Current status and future prospects. Report of experiences from the European Institute of Oncology (EIO), Mailand]
W Gatzemeier, R Orecchia, G Gatti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1983
Adjuvant CMF in breast cancer: comparative 5-year results of 12 versus 6 cycles
G Tancini, G Bonadonna, P Valagussa, et al.
Cancer
|
February 1, 1974
Proceedings: The value of staging laparotomy in non-Hodgkin's lymphomas (with emphasis on the histiocytic type)
U Veronesi, R Musumeci, F Pizzetti, et al.
International Advances in Surgical Oncology
|
January 1, 1983
The quadrantectomy, axillary dissection and radiotherapy (QU.A.RT) technique in early breast cancer
U Veronesi, M Del Vecchio, A Luini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 1, 1991
Chronic oral administration of fenretinide, as a chemopreventive agent to breast cancer patients, does not affect plasma alpha-tocopherol concentration
F Formelli, M Clerici, G De Palo, et al.
Page
of 27